Clinical efficacy of CDK4/6 inhibitor plus endocrine therapy in HR-positive/HER2-0 and HER2-low-positive metastatic breast cancer: a secondary analysis of PALOMA-2 and PALOMA-3 trials
2024 · EBioMedicine · 24 citations
https://doi.org/10.1016/j.ebiom.2024.105186